Twin City Private Wealth LLC Purchases Shares of 1,801 Stryker Corporation $SYK

Twin City Private Wealth LLC acquired a new position in shares of Stryker Corporation (NYSE:SYK) in the 1st quarter, Holdings Channel reports. The institutional investor acquired 1,801 shares of the medical technology company’s stock, valued at approximately $593,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Godfrey Financial Associates Inc. bought a new stake in shares of Stryker in the 4th quarter worth about $26,000. Sankala Group LLC bought a new position in Stryker during the 4th quarter valued at about $26,000. United Financial Planning Group LLC bought a new position in Stryker during the 3rd quarter valued at about $27,000. Atlas Capital Advisors Inc. acquired a new position in Stryker in the fourth quarter valued at about $27,000. Finally, DJE Kapital AG bought a new stake in Stryker during the fourth quarter worth about $28,000. 77.09% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Canaccord Genuity Group dropped their price objective on shares of Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a report on Friday, May 1st. Truist Financial restated a “hold” rating and set a $330.00 price target (down from $380.00) on shares of Stryker in a research report on Monday, May 4th. Leerink Partners dropped their price target on Stryker from $410.00 to $407.00 and set an “outperform” rating for the company in a report on Friday, June 5th. William Blair reiterated an “outperform” rating on shares of Stryker in a research report on Thursday, March 5th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Stryker in a research note on Friday, May 1st. Sixteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus target price of $395.33.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director owned 1,924,880 shares in the company, valued at $601,005,282.40. The trade was a 13.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP M Kathryn Fink sold 3,500 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $283.45, for a total value of $992,075.00. Following the sale, the vice president directly owned 177 shares of the company’s stock, valued at approximately $50,170.65. The trade was a 95.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 323,264 shares of company stock valued at $100,659,489 over the last 90 days. 4.60% of the stock is owned by company insiders.

Stryker Stock Performance

Shares of NYSE:SYK opened at $313.38 on Thursday. The firm’s 50 day simple moving average is $309.89 and its 200 day simple moving average is $339.15. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $404.87. The company has a market capitalization of $120.14 billion, a price-to-earnings ratio of 36.27, a P/E/G ratio of 2.02 and a beta of 0.78. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The firm had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. During the same period in the previous year, the company posted $2.84 EPS. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, sell-side analysts forecast that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.